# Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions

> **NCT05296122** · NA · COMPLETED · sponsor: **Clinical Laserthermia Systems AB** · enrollment: 14 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** TRANBERG® laser applicators when used in MR-guided laser thermal ablation of brain lesions using the TRANBERG® Thermal Therapy System and TRANBERG® Thermoguide Workstation.

## Key facts

- **NCT ID:** NCT05296122
- **Lead sponsor:** Clinical Laserthermia Systems AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-12
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05296122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05296122, "Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05296122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*